Forsell PK et al. |
Metabolism of anandamide into eoxamides by 15-lipoxygenase-1 and glutathione transferases. |
2012 |
Lipids |
pmid:22684912
|
Capra V et al. |
Cysteinyl-leukotrienes and their receptors in asthma and other inflammatory diseases: critical update and emerging trends. |
2007 |
Med Res Rev |
pmid:16894531
|
Kurogi Y |
Mesangial cell proliferation inhibitors for the treatment of proliferative glomerular disease. |
2003 |
Med Res Rev |
pmid:12424751
|
Bellamkonda K et al. |
The impact of inflammatory lipid mediators on colon cancer-initiating cells. |
2015 |
Mol. Carcinog. |
pmid:25154976
|
Shi ZZ et al. |
Disruption of gamma-glutamyl leukotrienase results in disruption of leukotriene D(4) synthesis in vivo and attenuation of the acute inflammatory response. |
2001 |
Mol. Cell. Biol. |
pmid:11463821
|
Campos MR et al. |
Differential kinase requirement for enhancement of Fc gammaR-mediated phagocytosis in alveolar macrophages by leukotriene B4 vs. D4. |
2009 |
Mol. Immunol. |
pmid:19223078
|
Capra V et al. |
Identification and characterization of two cysteinyl-leukotriene high affinity binding sites with receptor characteristics in human lung parenchyma. |
1998 |
Mol. Pharmacol. |
pmid:9547367
|
Kargman S et al. |
Protein kinase C-dependent regulation of sulfidopeptide leukotriene biosynthesis and leukotriene C4 synthase in neutrophilic HL-60 cells. |
1994 |
Mol. Pharmacol. |
pmid:8190095
|
Sarau HM et al. |
Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor. |
1999 |
Mol. Pharmacol. |
pmid:10462554
|
Ravasi S et al. |
A kinetic binding study to evaluate the pharmacological profile of a specific leukotriene C(4) binding site not coupled to contraction in human lung parenchyma. |
2000 |
Mol. Pharmacol. |
pmid:10825389
|
Nothacker HP et al. |
Molecular cloning and characterization of a second human cysteinyl leukotriene receptor: discovery of a subtype selective agonist. |
2000 |
Mol. Pharmacol. |
pmid:11093801
|
Zhao L et al. |
The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysm. |
2004 |
Nat. Med. |
pmid:15322539
|
Lynch KR et al. |
Characterization of the human cysteinyl leukotriene CysLT1 receptor. |
1999 |
Nature |
pmid:10391245
|
Wang XY et al. |
Leukotriene D4 induces amyloid-β generation via CysLT(1)R-mediated NF-κB pathways in primary neurons. |
2013 |
Neurochem. Int. |
pmid:23318673
|
Schuhmann MU et al. |
Temporal profiles of cerebrospinal fluid leukotrienes, brain edema and inflammatory response following experimental brain injury. |
2003 |
Neurol. Res. |
pmid:12866196
|
Dudek SM and Friedlander MJ |
Developmental down-regulation of LTD in cortical layer IV and its independence of modulation by inhibition. |
1996 |
Neuron |
pmid:8663986
|
Conroy DM et al. |
Relaxant effects of pituitary adenylate cyclase activating polypeptide (PACAP) on epithelium-intact and -denuded guinea-pig trachea: a comparison with vasoactive intestinal peptide (VIP). |
1995 |
Neuropeptides |
pmid:8538872
|
Tang SS et al. |
Leukotriene D4 induces cognitive impairment through enhancement of CysLT₠R-mediated amyloid-β generation in mice. |
2013 |
Neuropharmacology |
pmid:22982445
|
Kang KH et al. |
Protection of dopaminergic neurons by 5-lipoxygenase inhibitor. |
2013 |
Neuropharmacology |
pmid:23800665
|
Hoheisel U and Mense S |
Leukotriene D4 depresses the mechanosensitivity of group III and IV muscle receptors in the rat. |
1994 |
Neuroreport |
pmid:8025261
|